Devitrification of ionomer glass and its effect on the in vitro biocompatibility of glass-ionomer cements.
The effects of devitrification of an ionomer glass with a molar composition 4.5SiO(2).3Al(2)O(3).1.5P(2)O(5).3CaO.2CaF(2) on cement formation and in vitro biocompatibility were investigated. Differential thermal analysis was used to study the phase evolution in the glass, and to determine the heat treatments for production of glass-ceramics. X-ray diffraction patterns from glass frit heat-treated at 750 degrees C for 2h contained peaks corresponding to apatite (JCPDS 15-876), whereas for samples heat-treated at 950 degrees C for 2h apatite and mullite (JCPDS 15-776) were the major phases detected. Transmission electron microscopy (TEM) confirmed that apatite and apatite-mullite phases were present after heat treatments at 750 degrees C and 950 degrees C respectively. Glass and glass-ceramics were ground to prepare <45microm powders and glass ionomer cements were produced using a ratio of 1g powder: 0.2g PAA: 0.3g 10% m/v tartaric acid solution in water. In vitro biocompatibility was evaluated using cultured rat osteosarcoma (ROS) cells. Scanning electron microscopy (SEM) showed that cells colonised the surfaces of cements prepared using untreated ionomer glass and glass crystallised to form apatite (750 degrees C/2h). However, quantitative evaluation using MTT and total protein assays indicated that more cell growth occurred in the presence of cements prepared using ionomer glasses crystallised to apatite than cements prepared using untreated glass. The least cell growth and respiratory activity was observed on cements made with crystallised glass containing both apatite and mullite. It was concluded that the controlled devitrification of ionomer glasses could be used to produce GIC bone cements with improved biocompatibility.
Hurrell-Gillingham
K
K
Department of Engineering Materials, Sir Robert Hadfield Building, University of Sheffield, Sheffield S1 3JD, UK.
Reaney
I M
IM
Miller
C A
CA
Crawford
A
A
Hatton
P V
PV
D000818:Animals; D001672:Biocompatible Materials / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D045744:Cell Line, Tumor; D003460:Crystallization / Q000379:methods*; D005899:Glass Ionomer Cements / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology*; D006358:Hot Temperature; D008422:Materials Testing; D008968:Molecular Conformation; D012516:Osteosarcoma / Q000378:metabolism* / Q000648:ultrastructure*; D044367:Phase Transition; D051381:Rats
D001672:Biocompatible Materials; D005899:Glass Ionomer Cements